0001209191-24-002479.txt : 20240131
0001209191-24-002479.hdr.sgml : 20240131
20240131162528
ACCESSION NUMBER: 0001209191-24-002479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn James P
CENTRAL INDEX KEY: 0001955965
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 24583276
MAIL ADDRESS:
STREET 1: 41 HARRIS CT
CITY: DANVILLE
STATE: CA
ZIP: 94526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10170 CHURCH RANCH WAY
STREET 2: SUITE 100
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
BUSINESS PHONE: 7209402200
MAIL ADDRESS:
STREET 1: 10170 CHURCH RANCH WAY
STREET 2: SUITE 100
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-30
0
0000907654
ARCA biopharma, Inc.
ABIO
0001955965
Flynn James P
10170 CHURCH RANCH WAY
SUITE 100
WESTMINSTER
CO
80021
1
0
0
0
0
Stock Option (right to buy)
1.64
2024-01-30
4
A
0
6000
0.00
A
2034-01-30
Common Stock
6000
6000
D
Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.
/s/ C. Jeffrey Dekker, Attorney-in-Fact
2024-01-31